-- Prominent consumer food industry executive will help guide
commercialization strategy for innovative health and nutrition
DAVIS, Calif.--(BUSINESS WIRE)--May 15, 2018--
Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient
company, announced today that Albert D. Bolles, Ph.D., a leading
consumer food industry executive, has joined its board of directors.
Bolles is the former executive vice president, chief technology and
operations officer of ConAgra Foods, where he led a technical
organization including research, quality, innovation, and supply chain
functions with over 10,000 employees and 100 manufacturing facilities.
In his time with ConAgra, Bolles directed the development and execution
of multiple product innovations and a multi-year pipeline to sustain and
advance growth and, prior to joining ConAgra, he served as vice
president, worldwide R&D for PepsiCo Beverages and Foods, and R&D
director for Gerber Foods.
As an active partner with the Food and Drug Administration and U.S.
Department of Agriculture to influence public policy, Bolles was
instrumental in the passage of the Food Safety Modernization Act of
2010. Bolles is a graduate of Michigan State University where he earned
Ph.D. and M.S. degrees in food science, and a bachelors’ degree in
microbiology. He holds several patents and has won numerous awards for
his contributions to food science, the industry and academics.
“Al is a visionary leader in the industry with proven success in global
product innovation, R&D and corporate strategy,” said Kevin Comcowich,
chair of Arcadia’s board of directors. “He will be instrumental in
helping Arcadia build the commercial capabilities and industry
relationships needed to launch its value-added food ingredients
“Arcadia has a robust pipeline of innovations in its non-GM wheat
platform and other nutritional products that fit consumer needs in
health and wellness,” said Bolles. “Their GoodWheat™ family of products
has tremendous promise in the global marketplace, and I’m excited to
join the board and leverage my experience and industry relationships to
maximize its potential.”
About Arcadia Biosciences, Inc.
Arcadia Biosciences (Nasdaq: RKDA) develops and markets high-value food
ingredients and nutritional oils that help meet consumer demand for a
healthier diet. Arcadia’s GoodWheat™ branded ingredients deliver health
benefits to consumers and enable consumer packaged goods companies to
differentiate their brands in the marketplace. The company’s portfolio
of agricultural traits are being developed to enable farmers around the
world to be more productive and minimize the impact of agriculture on
the environment. For more information, visit www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially, and reported results
should not be considered as an indication of future performance. These
risks and uncertainties include, but are not limited to: the company’s
and its partners’ and affiliates’ ability to identify and isolate
desired traits; the demand for the company’s product’s, both from
commercial partners and consumers; the company’s and its partners’
ability to develop commercial products incorporating its traits and
complete the regulatory review process for such products; the company’s
compliance with laws and regulations that impact the company’s business,
and changes to such laws and regulations; the company’s future capital
requirements and ability to satisfy its capital needs; and the other
risks set forth in the company’s filings with the Securities and
Exchange Commission from time to time, including the risks set forth in
the company’s annual report on Form 10-K for the year ended December 31,
2017 and other filings. These forward-looking statements speak only as
of the date hereof, and Arcadia Biosciences, Inc. disclaims any
obligation to update these forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180515005918/en/
Source: Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc.
Jeff Bergau, +1-312-217-0419